Home Cart 0 Sign in  
X

[ CAS No. 5378-52-9 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
HazMat Fee +

There will be a HazMat fee per item when shipping a dangerous goods. The HazMat fee will be charged to your UPS/DHL/FedEx collect account or added to the invoice unless the package is shipped via Ground service. Ship by air in Excepted Quantity (each bottle), which is up to 1g/1mL for class 6.1 packing group I or II, and up to 25g/25ml for all other HazMat items.

Type HazMat fee for 500 gram (Estimated)
Excepted Quantity USD 0.00
Limited Quantity USD 15-60
Inaccessible (Haz class 6.1), Domestic USD 80+
Inaccessible (Haz class 6.1), International USD 150+
Accessible (Haz class 3, 4, 5 or 8), Domestic USD 100+
Accessible (Haz class 3, 4, 5 or 8), International USD 200+
3d Animation Molecule Structure of 5378-52-9
Chemical Structure| 5378-52-9
Chemical Structure| 5378-52-9
Structure of 5378-52-9 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 5378-52-9 ]

Related Doc. of [ 5378-52-9 ]

Alternatived Products of [ 5378-52-9 ]

Product Details of [ 5378-52-9 ]

CAS No. :5378-52-9 MDL No. :MFCD00463625
Formula : C7H6N4 Boiling Point : -
Linear Structure Formula :- InChI Key :IYPXPGSELZFFMI-UHFFFAOYSA-N
M.W : 146.15 Pubchem ID :138477
Synonyms :

Calculated chemistry of [ 5378-52-9 ]

Physicochemical Properties

Num. heavy atoms : 11
Num. arom. heavy atoms : 11
Fraction Csp3 : 0.0
Num. rotatable bonds : 1
Num. H-bond acceptors : 3.0
Num. H-bond donors : 0.0
Molar Refractivity : 39.15
TPSA : 43.6 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : No
CYP1A2 inhibitor : No
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -6.42 cm/s

Lipophilicity

Log Po/w (iLOGP) : 1.6
Log Po/w (XLOGP3) : 1.09
Log Po/w (WLOGP) : 0.66
Log Po/w (MLOGP) : 1.38
Log Po/w (SILICOS-IT) : 0.59
Consensus Log Po/w : 1.07

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 1.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -2.11
Solubility : 1.14 mg/ml ; 0.00782 mol/l
Class : Soluble
Log S (Ali) : -1.6
Solubility : 3.69 mg/ml ; 0.0252 mol/l
Class : Very soluble
Log S (SILICOS-IT) : -2.16
Solubility : 1.01 mg/ml ; 0.00692 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 0.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 1.56

Safety of [ 5378-52-9 ]

Signal Word:Danger Class:4.1
Precautionary Statements:P240-P210-P241-P264-P280-P302+P352-P370+P378-P337+P313-P305+P351+P338-P362+P364-P332+P313 UN#:1325
Hazard Statements:H315-H319-H228 Packing Group:
GHS Pictogram:

Application In Synthesis of [ 5378-52-9 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Downstream synthetic route of [ 5378-52-9 ]

[ 5378-52-9 ] Synthesis Path-Downstream   1~85

  • 1
  • [ 5378-52-9 ]
  • [ 1600-27-7 ]
  • [ 123474-25-9 ]
  • 2
  • [ 5378-52-9 ]
  • [ 108-24-7 ]
  • [ 102-03-4 ]
  • 3
  • [ 5378-52-9 ]
  • furan-2,3,5(4H)-trione pyridine (1:1) [ No CAS ]
  • [ 622-34-4 ]
  • 6
  • [ 628-36-4 ]
  • [ 100-34-5 ]
  • furan-2,3,5(4H)-trione pyridine (1:1) [ No CAS ]
  • [ 5378-52-9 ]
  • 8
  • [ 55-21-0 ]
  • [ 5378-52-9 ]
  • 9
  • [ 100-52-7 ]
  • [ 5378-52-9 ]
  • [ 100-47-0 ]
  • 10
  • [ 5378-52-9 ]
  • [ 50-00-0 ]
  • [ 506-59-2 ]
  • [ 109817-60-9 ]
  • 11
  • [ 17743-33-8 ]
  • [ 5378-52-9 ]
  • [ 106-48-9 ]
  • 13
  • [ 17743-32-7 ]
  • [ 5378-52-9 ]
  • [ 91-20-3 ]
  • [ 135-19-3 ]
  • 14
  • [ 17743-27-0 ]
  • [ 5378-52-9 ]
  • [ 92-52-4 ]
  • [ 92-69-3 ]
  • 16
  • [ 82479-16-1 ]
  • [ 5378-52-9 ]
  • [ 105-67-9 ]
  • 17
  • [ 82479-14-9 ]
  • [ 5378-52-9 ]
  • [ 500-99-2 ]
  • 18
  • [ 82479-18-3 ]
  • [ 5378-52-9 ]
  • [ 26886-05-5 ]
  • 19
  • [ 82479-15-0 ]
  • [ 5378-52-9 ]
  • [ 91-10-1 ]
  • 20
  • [ 82479-17-2 ]
  • [ 5378-52-9 ]
  • [ 642-71-7 ]
  • 23
  • [ 82485-86-7 ]
  • [ 5378-52-9 ]
  • [ 576-26-1 ]
  • 24
  • [ 1483-25-6 ]
  • [ 5378-52-9 ]
  • [ 108-95-2 ]
  • 25
  • [ 126814-02-6 ]
  • [ 5378-52-9 ]
  • [ 126814-05-9 ]
  • 26
  • [ 122-51-0 ]
  • [ 62-53-3 ]
  • [ 5378-52-9 ]
YieldReaction ConditionsOperation in experiment
96% With sodium azide; iron(III) chloride adsorbed on silica gel; In neat (no solvent); at 45℃; for 2.0h;Sonication; Green chemistry; General procedure: FeCl3-SiO2 (0.02 g) was added to a mixture of amine (2 mM), NaN3 (2 mM), triethyl orthoformate (2.4 mM) and stirred at 130 C or sonicated in an ultrasonic cleaner water bath at 45 C for the appropriate time (Table 2). After completion (as monitored by TLC), the reaction mixture was diluted with cold water (5 mL) and extracted with ethyl acetate (3×10 mL). The catalyst was removed by filtration and the combined organic layers were washed with brine and dried over anhydrous Na2SO4. After concentration, the product was crystallised from EtOAc-hexane to afford the pure product.
96% With sodium azide; In neat (no solvent); at 100℃; for 1.66667h;Catalytic behavior; General procedure: A mixture of amine 1a-1j (2 mmol), sodium azide (0.13 g, 2 mmol), triethyl orthoformate (0.296 g, 2 mmol), and Co nanocatalyst (50 mg) was stirred at 100C until TLC monitoring showed no further conversion. When the reaction mixture cooled down to room temperature, the catalyst was separated with a strong magnet, the mixture was poured onto ice, and the organic layer was treated with ethyl acetate (2 × 20 mL). The combined extract was dried over dry MgSO4, the solvent was evaporated, and the solid residue was recrystallized from ethyl acetate-hexane (1 : 10). Selected spectral data for the synthesized tetrazole derivatived. 1-Phenyl-1H-tetrazole (2a). FTIR spectrum (KBr), nu, cm-1: 3051, 2925, 1678, 1660, 619 and 593. 1H NMR spectrum (CDCl3), delta, ppm: 8.27 s (1H), 6.98-7.60 m (5H).
95% With sodium azide; In water; at 70℃; for 1.0h; General procedure: Amine (1.0mmol), HC(OEt)3 (1.0mmol) and NaN3 (1.3mmol) were mixed and stirred in water (2mL) in the presence of 4mol-% of [AMWCNTs-O-Cu(II)-PhTPY] at 70C in an uncapped vial. After the completion of the reaction, as monitored by TLC using n-hexane/ethyl acetate, the mixture was diluted by H2O (5mL), then the mixture was vacuum-filtered onto a sintered-glass funnel, and the residue was consecutively washed with ethyl acetate (30mL), water (5mL). The combined supernatant and organic washings were extracted with ethyl acetate (3×10mL), the combined organic layer was dried over anhydrous Na2SO4. Removal of the solvent under vacuum, followed by purification on silica gel using hexane/ethyl acetate as the eluent afforded the pure products.
95% With 1-n-butyl-3-methylimidazolium azide; In water; at 60℃; for 0.5h;Green chemistry;Catalytic behavior; Fe3O4WO3-EAE-SO3H (III) (0.01 g) was added to a solutionof aniline (0.093 g, 1.0 mmol), triethyl orthoformate (0.177 g,1.2 mmol) and 1-butyl-3-methylimidazolium azide (0.216 g,1.2 mmol) in water (5 mL). The reaction mixture was allowedto stir magnetically at 60 C for 30 min. After completion ofthe reaction (as monitored by TLC), the reaction mixture wascooled to room temperature and the catalyst was separated withan external magnet. Then the resulting solution was extracted with EtOAc (3 15 mL). The organic layer was washedwith brine, dried over anhydrous Na2SO4 and evaporated underreduced pressure. The crude product was recrystallized fromethylacetate/n-hexane (1/9 v/v) to afford the pure 1-phenyl-1H-tetrazole (1.48 g, 95%). The recovered catalyst was washedwith hot ethyl acetate, dried at 60 C for 2 h and reused forsubsequent cycles.
93% With sodium azide; In neat (no solvent); at 100℃; for 0.75h;Catalytic behavior; General procedure: A mixture of amine (1 mmol), sodium azide (1 mmol), triethyl ortho-formate (1.2 mmol) and catalyst (0.01 g, 0.4 mol% of Cu(II)) was taken in a round-bottomed flask and stirred at 100 C. The progress of the reaction was followed by thin-layer chromatography (TLC). After completion of the reaction, the reaction mixture was cooled to room temperature and diluted with ethyl acetate (2 × 20 mL). The catalyst was removed by using magnetic field and then the resulting solution was washed with water, dried over anhydrous Na2SO4 and was evaporated. The residue was concentrated and recrystallized from EtOAc-hexane (1:10).
92% With sodium azide; In neat (no solvent); at 100℃; for 1.25h; General procedure: A mixture of amine (1mmol), sodium azide (1.2 mmol), triethyl orthoformate (1.2 mmol) and catalyst (0.02 g, contains 0.4 mol% of Cu(II)) was taken in a round-bottomed flask and stirred at 100 C. The progress of the reaction was followed by thin-layer chromatography (TLC). After completion of the reaction, the reaction mixture was cooled to room temperature and diluted with ethyl acetate (3×20 mL). The catalyst was removed by using magnetic field or filtration and then the resulting solution was washed with water, dried over anhydrous Na2SO4 and was evaporated. The residue was concentrated and recrystallized from EtOAc-hexane (1:9). All products were characterized by 1H, 13C NMR, FT-IR, and melting point which were in agreement with literature. We have reported the spectral data of some aromatic and heteroaromatic synthesized compounds.
92% With sodium azide; zinc sulfide; In N,N-dimethyl-formamide; at 20℃; for 0.333333h;Sonication; General procedure: A mixture of selected primary amine (1mmol), triethyl orthoformate (1.2mmol) and sodium azide (1mmol) in the presence of 0.01g ZnS nanoparticles was added to N,N-dimethylformamide as solvent and the reaction mixture was irradiated in ultrasonic apparatus with the power 50W. The progress of the reaction was monitored by thin layer chromatography (TLC). After completion of the reaction, the mixture was diluted by 1:1 H2O:ethylacetate (10ml), stirred at ambient temperature (20min) and centrifuged to separate the solid catalyst. The organic layer of the solution was separated, dried over sodium sulfate, and the organic solvent and other residues were stripped in a vacuum evaporator. The product was purified by recrystallization in a mixture of EtOAc:MeOH (3:1) to yield pure product. The obtained pure tetrazoles were characterized by spectroscopic data and melting points.
92% With sodium azide; bis(trifluoromethanesulfonyl)amide; In glycerol; at 20℃; for 3.0h;Green chemistry;Catalytic behavior; General procedure: A mixture of amine (2 mmol), sodium azide (2 mmol), triethylorthoformate (2.4 mmol), glycerol (8 mL) and HNTf2 (5 mol%) wastaken in a round bottomed flask and stirred at room temperature. Theprogress of the reaction was monitored by TLC. After completion, thereaction mixture was diluted with cold water (5 mL) and extracted witha mixture of hexane/ethyl acetate 95:5 (3 × 10 mL). The combinedorganic layers were washed with brine and dried over anhydrousNa2SO4. The residue was concentrated and recrystallised from ethylacetate/hexane 2:1 to afford the pure product.
90% With sodium azide; cobalt ferrite; In neat (no solvent); at 120℃; for 2.0h;Green chemistry; General procedure: CoFe2O4 magnetic nanocatalyst (20 mol%) was added toa mixture of amine (2 mmol), NaN3 (2 mmol), triethyl orthoformate(2.4 mmol) and stirred at 120 oC for 2 h (Table 1). After completion of the reaction, the catalyst was separated from the reaction mixture with an external magnet and the reaction mixture was diluted with cold water (5 mL) and extracted with ethyl acetate (10 mL 3). The combined organic layers were washed with brine and dried over anhydrous Na2SO4. After concentration, a crystallization step was performed using EtOAc-petroleum ether to afford the pure product. All of the desired product(s) were characterized by comparison of their physical data with those of known compounds[6,7,17].
90% With sodium azide; In neat (no solvent); at 100℃; for 1.33333h; A mixture of 2 mmol of aromatic amine 1a-1j, 0.13 g (2 mmol) of sodium azide, 0.296 g (2 mmol) of triethyl orthoformate, and 50 mg of the copper nanocatalyst was stirred at 100 C until no further progress in the conversion was observed according to the TLC data. The mixture was allowed to cool down to room temperature, the catalyst was separated by strong magnet, the mixture was poured onto ice, and the organic layer was extracted with ethyl acetate (2 × 20 mL). The combined extracts were dried over anhydrous MgSO4, filtered, and evaporated, and the residue was recrystallized from ethyl acetate-hexane (1 : 10). The yields and melting points of tetrazoles 2a-2j are given in Table 4. 1-Phenyl-1H-tetrazole (2a). IR spectrum (KBr), nu, cm-1: 3051, 2925, 2854, 1678, 1660, 1585, 1487, 1448, 1316, 1279, 1227, 1209, 1171, 1153, 1076, 986, 899, 806, 765, 754, 694, 619, 593. 1H NMR spectrum (90 MHz, CDCl3), delta, ppm: 8.27 s (1H), 6.98-7.60 m (5H).
89% With sodium azide; In neat (no solvent); at 120℃; for 4.0h;Green chemistry;Catalytic behavior; General procedure: HClO4-SiO2 (0.08 g) was added to a mixture of amine (2 mmol), NaN3 (2 mmol), triethyl orthoformate (2.4 mmol) and stirred at 120 C for the appropriate time (Table 1). After completion (as monitored by TLC), the reaction mixture was diluted with cold water (5 mL) and extracted with ethyl acetate (10 mL ? 3). The catalyst was removed by filtration. The combined organic layers were washed with brine and dried over anhydrous Na2SO4. After concentration, a crystallizaton step was performed using EtOAc-hexane to afford the pure product. The physical data (mp, IR, NMR) of known compounds were found to be identical with those reported in the literature [9,10,11,12a,15].
With sodium azide; acetic acid; at 80℃; for 4.0h;Green chemistry; Aniline (10 mmol, 930 mg), sodium azide (11 mmol, 715 mg), triethyl orthoformate (30 mmol, 4440 mg) and glacial acetic acid (80 mmol, 4800 mg) were added to a 100 mL reaction flask.The mixture was stirred in an oil bath at 80 C for 4 hours, cooled to room temperature, diluted with saturated brine (100 mL) and finally sodium carbonate was added until the evolution of the gas was stopped, filtered, washed with water and dried in vacuo at 50 C to give phenyl- 1H-tetrazole.
With sodium azide; acetic acid; at 80℃; for 24.0h; General procedure: The mono1-aryl-1H-tetrazoles 1a-f were synthesized by the literature method.[35,36] The1-substituted-aryl-amine (10 mmol) was treated with sodium azide (10 mmol), triethylorthoformate (10 mmol) in 100mL of acetic acid. It was refluxed for 24 h at 80 C. Thereaction progress was checked by TLC. Once the reaction was completed, the reactionmixture was transferred into a beaker containing ice. The solid product was separatedon cooling, filtered and dried. The equimolar mixture of 1-substituted-aryl-tetrazole(5 mmol) 1a-f is treated with ethyl-2-chloro-2-oxoacetate (5 mmol) in the presence of acatalytic amount of DIPEA in THF (100 mL) (Scheme 1). It was refluxed for 16 h. Theprocess of the reaction was checked by TLC. After the formation of a product, the reactionmixture was poured into ice. The solid product was separated, filtered and dried.The compound was purified by column chromatography using the pet ether and benzenein the ratio 7:3. The yield of the product was 88-95%. Then, the title compound(0.5 g) was synthesized by hydrolysis of compounds 3a-f in the presence ofConcentrated HCl (1 mL) and 10mL of ethanol (Scheme 1). The reaction was refluxedfor 6 h. The formation of the product was confirmed with the help of TLC and the reactionwas quenched by pouring the mixture into ice. The solid product was filtered offand dried. The products 4a-f were obtained in good yield of 90%.

Reference: [1]Dalton Transactions,2014,vol. 43,p. 12967 - 12973
[2]Journal of Chemical Research,2013,vol. 37,p. 464 - 466
[3]Applied Organometallic Chemistry,2016,vol. 30,p. 897 - 904
[4]Applied Organometallic Chemistry,2020,vol. 34
[5]Russian Journal of Organic Chemistry,2019,vol. 55,p. 1777 - 1784
[6]Journal of Organometallic Chemistry,2013,vol. 738,p. 41 - 48
[7]Bulletin of the Chemical Society of Japan,2017,vol. 90,p. 1119 - 1128
[8]Green Chemistry,2011,vol. 13,p. 3499 - 3504
[9]Monatshefte fur Chemie,2013,vol. 144,p. 725 - 728
[10]Heterocycles,2014,vol. 89,p. 2137 - 2150
[11]Journal of Molecular Catalysis A: Chemical,2014,vol. 393,p. 18 - 29
[12]Journal of Organometallic Chemistry,2013,vol. 743,p. 87 - 96
[13]Ultrasonics Sonochemistry,2015,vol. 27,p. 408 - 415
[14]Journal of Chemical Research,2016,vol. 40,p. 570 - 572
[15]Applied Organometallic Chemistry,2018,vol. 32
[16]European Journal of Organic Chemistry,2011,p. 2827 - 2835
[17]Letters in Organic Chemistry,2013,vol. 10,p. 527 - 531
[18]Russian Journal of Organic Chemistry,2019,vol. 55,p. 1591 - 1597
    Zh. Org. Khim.,2019
[19]Tetrahedron Letters,2007,vol. 48,p. 1721 - 1724
[20]Letters in Organic Chemistry,2014,vol. 11,p. 55 - 58
[21]Tetrahedron Letters,2009,vol. 50,p. 6139 - 6142
[22]RSC Advances,2013,vol. 3,p. 4362 - 4371
[23]Chemistry of Heterocyclic Compounds,1985,vol. 21,p. 1255 - 1258
    Khimiya Geterotsiklicheskikh Soedinenii,1985,vol. 21,p. 1521 - 1524
[24]European Journal of Organic Chemistry,2006,p. 2723 - 2726
[25]Journal of Materials Chemistry A,2017,vol. 5,p. 7366 - 7371
[26]Chemistry of Heterocyclic Compounds,1985,vol. 21,p. 1255 - 1258
    Khimiya Geterotsiklicheskikh Soedinenii,1985,vol. 21,p. 1521 - 1524
[27]Synthesis,2006,p. 1307 - 1312
[28]Advanced Synthesis and Catalysis,2013,vol. 355,p. 765 - 780
[29]Journal of the Iranian Chemical Society,2014,vol. 11,p. 91 - 99
[30]Patent: CN104086485,2016,B .Location in patent: Paragraph 0042; 0043
[31]Synthetic Communications,2019,vol. 49,p. 1913 - 1925
[32]Journal of Heterocyclic Chemistry,2019,vol. 56,p. 2779 - 2786
  • 28
  • [ 107269-94-3 ]
  • [ 5378-52-9 ]
  • [ 14213-16-2 ]
  • 29
  • [ 16484-16-5 ]
  • [ 5378-52-9 ]
  • 31
  • [ 513-81-5 ]
  • 5-(1-phenyl)-1,2,3,4-tetrazolyl acetylmethyl sulfoxide [ No CAS ]
  • [ 5378-52-9 ]
  • 1-(4,5-Dimethyl-1-oxo-1,2,3,6-tetrahydro-1λ4-thiopyran-2-yl)-ethanone [ No CAS ]
  • 32
  • [ 513-81-5 ]
  • 5-(1-phenyl)-1,2,3,4-tetrazolyl phenacyl sulfoxide [ No CAS ]
  • [ 5378-52-9 ]
  • [ 131497-54-6 ]
  • 33
  • 5-(1-phenyl)-1,2,3,4-tetrazolyl acetylmethyl sulfoxide [ No CAS ]
  • [ 5378-52-9 ]
  • 1-(4,5-Dimethyl-1-oxo-1,2,3,6-tetrahydro-1λ4-thiopyran-2-yl)-ethanone [ No CAS ]
  • 34
  • 5-(1-phenyl)-1,2,3,4-tetrazolyl phenacyl sulfoxide [ No CAS ]
  • [ 5378-52-9 ]
  • [ 131497-54-6 ]
  • 35
  • [ 5378-52-9 ]
  • [ 75-65-0 ]
  • 3-tert-butyl-1-phenyl-1H-tetrazolium perchlorate [ No CAS ]
  • 36
  • [ 5378-52-9 ]
  • [ 88-89-1 ]
  • [ 109-89-7 ]
  • [ 75-65-0 ]
  • N-tert-butyl-N',N'-diethyl-N''-phenylguanidine [ No CAS ]
  • 37
  • [ 5378-52-9 ]
  • [ 88-89-1 ]
  • [ 77-78-1 ]
  • 2-methyl-4-phenyl-4<i>H</i>-tetrazol-2-ium; picrate [ No CAS ]
  • 1-phenyl-4-methyltetrazolium picrate [ No CAS ]
  • 38
  • [ 5378-52-9 ]
  • [ 88-89-1 ]
  • [ 75-65-0 ]
  • 2-<i>tert</i>-butyl-4-phenyl-4<i>H</i>-tetrazol-2-ium; picrate [ No CAS ]
  • 1-<i>tert</i>-butyl-4-phenyl-4<i>H</i>-tetrazol-1-ium; picrate [ No CAS ]
  • 39
  • [ 110-89-4 ]
  • [ 222178-94-1 ]
  • [ 5378-52-9 ]
  • dimethylphosphorylthioformic acid piperidide [ No CAS ]
  • 40
  • [ 110-91-8 ]
  • [ 222178-94-1 ]
  • [ 5378-52-9 ]
  • dimethylphosphorylthioformic acid morpholide [ No CAS ]
  • 41
  • [ 109-97-7 ]
  • [ 222178-94-1 ]
  • [ 5378-52-9 ]
  • (dimethyl-phosphinoyl)-pyrrol-1-yl-methanethione [ No CAS ]
  • 42
  • [ 62-53-3 ]
  • [ 222178-94-1 ]
  • [ 5378-52-9 ]
  • dimethylphosphorylthioformic acid anilide [ No CAS ]
  • 43
  • [ 100-46-9 ]
  • [ 222178-94-1 ]
  • [ 5378-52-9 ]
  • dimethylphosphorylthioformic acid benzylamide [ No CAS ]
  • 44
  • [ 513-81-5 ]
  • 5-(1-phenyl)-1,2,3,4-tetrazolyl acetylmethyl sulfoxide [ No CAS ]
  • [ 5378-52-9 ]
  • 1-((1S,2S)-4,5-Dimethyl-1-oxo-1,2,3,6-tetrahydro-1λ4-thiopyran-2-yl)-ethanone [ No CAS ]
  • 1-((1R,2S)-4,5-Dimethyl-1-oxo-1,2,3,6-tetrahydro-1λ4-thiopyran-2-yl)-ethanone [ No CAS ]
  • 45
  • [ 513-81-5 ]
  • 5-(1-phenyl)-1,2,3,4-tetrazolyl phenacyl sulfoxide [ No CAS ]
  • [ 5378-52-9 ]
  • [ 96745-96-9 ]
  • [ 96745-95-8 ]
  • 46
  • [ 513-81-5 ]
  • 5-(1-phenyl)-1,2,3,4-tetrazolyl ethoxycarbonylmethyl sulfoxide [ No CAS ]
  • [ 5378-52-9 ]
  • cis-6-ethoxycarbonyl-5,6-dihydro-3,4-dimethyl-2H-thiapyran 1-oxide [ No CAS ]
  • trans-6-ethoxycarbonyl-5,6-dihydro-3,4-dimethyl-2H-thiapyran 1-oxide [ No CAS ]
  • 47
  • [ 513-81-5 ]
  • 2-[5'-(1'-phenyl)-1,2,3,4-tetrazolylsulfinyl]propiophenone [ No CAS ]
  • [ 5378-52-9 ]
  • [ 58753-23-4 ]
  • 48
  • [ 513-81-5 ]
  • 2-[5'-(1'-phenyl)-1,2,3,4-tetrazolylsulfinyl]propiophenone [ No CAS ]
  • [ 5378-52-9 ]
  • 6-benzoyl-5,6-dihydro-3,4,6-trimethyl-2H-thiapyran 1-oxide [ No CAS ]
  • 49
  • [ 513-81-5 ]
  • 2-[5'-(1'-phenyl)-1,2,3,4-tetrazolylsulfinyl]indanone [ No CAS ]
  • [ 5378-52-9 ]
  • 5,6-dihydro-3,4-dimethyl-2H-thiapyran-6-spiro-2'-indanone 1-oxide [ No CAS ]
  • 50
  • [ 513-81-5 ]
  • 2-[5'-(1'-phenyl)-1,2,3,4-tetrazolylsulfinyl]2-phenylacetophenone [ No CAS ]
  • [ 5378-52-9 ]
  • [ 96745-94-7 ]
  • 51
  • 2-[5'-(1'-phenyl)-1,2,3,4-tetrazolylsulfinyl]propiophenone [ No CAS ]
  • [ 5378-52-9 ]
  • [ 768-03-6 ]
  • 5-(1-phenyl)-1,2,3,4-tetrazolyl benzoylethyl sulfoxide [ No CAS ]
  • 54
  • 1-phenyl-5-anilino-tetrazole [ No CAS ]
  • [ 5378-52-9 ]
  • 56
  • [ 18233-34-6 ]
  • [ 10034-85-2 ]
  • [ 5378-52-9 ]
  • 57
  • [ 86-93-1 ]
  • [ 7664-41-7 ]
  • [ 7732-18-5 ]
  • [ 7722-84-1 ]
  • [ 5378-52-9 ]
  • 58
  • [ 86-93-1 ]
  • [ 64-19-7 ]
  • chromic acid anhydride [ No CAS ]
  • [ 5378-52-9 ]
  • 59
  • [ 100-34-5 ]
  • diformylhydrazine [ No CAS ]
  • [ 5378-52-9 ]
  • 60
  • [ 18233-34-6 ]
  • Na2SO3 [ No CAS ]
  • [ 5378-52-9 ]
  • 61
  • [ 5117-07-7 ]
  • diluted NaOH-solution [ No CAS ]
  • [ 5378-52-9 ]
  • [ 86-93-1 ]
  • 62
  • [ 7647-01-0 ]
  • [ 123474-25-9 ]
  • [ 5378-52-9 ]
  • 63
  • [ 100-34-5 ]
  • symm.diformylhydrazine [ No CAS ]
  • alkali [ No CAS ]
  • [ 5378-52-9 ]
  • 64
  • [ 5378-52-9 ]
  • [ 123-42-2 ]
  • 2-(1,1-dimethyl-3-oxo-butyl)-4-phenyl-4<i>H</i>-tetrazol-2-ium; perchlorate [ No CAS ]
  • 65
  • [ 110-89-4 ]
  • [ 5378-52-9 ]
  • [ 50-00-0 ]
  • [ 116496-58-3 ]
  • 66
  • [ 5378-52-9 ]
  • [ 2857-97-8 ]
  • [ 30543-46-5 ]
  • 67
  • [ 5378-52-9 ]
  • [ 77-78-1 ]
  • 4-methyl-1-phenyl-1H-tetrazolium perchlorate [ No CAS ]
  • 3-methyl-1-phenyl-1H-tetrazolium perchlorate [ No CAS ]
  • 68
  • [ 5378-52-9 ]
  • [ 77-78-1 ]
  • [ 4172-91-2 ]
  • 69
  • [ 5378-52-9 ]
  • [ 75-65-0 ]
  • [ 2219-34-3 ]
  • 70
  • [ 5378-52-9 ]
  • [ 75-65-0 ]
  • 4-tert-butyl-1-phenyl-1H-tetrazolium perchlorate [ No CAS ]
  • 3-tert-butyl-1-phenyl-1H-tetrazolium perchlorate [ No CAS ]
  • 71
  • [ 5378-52-9 ]
  • [ 5467-78-7 ]
  • 72
  • [ 5378-52-9 ]
  • [ 73027-64-2 ]
  • 73
  • [ 5378-52-9 ]
  • [ 73027-62-0 ]
  • 74
  • [ 5378-52-9 ]
  • N'-methyl-N-(2,4,6-trinitrophenyl)-N'-phenylurea [ No CAS ]
  • 75
  • [ 1197040-29-1 ]
  • acid [ No CAS ]
  • [ 5378-52-9 ]
  • 77
  • [ 107269-65-8 ]
  • [ 5378-52-9 ]
  • 78
  • [ 107269-89-6 ]
  • [ 5378-52-9 ]
  • 80
  • [ 14210-25-4 ]
  • [ 5378-52-9 ]
  • 81
  • [ 5378-52-9 ]
  • [ 14213-13-9 ]
  • 83
  • [ 5378-52-9 ]
  • allyl-(1-phenyl-1<i>H</i>-tetrazol-5-yl)-amine [ No CAS ]
  • 84
  • [ 5378-52-9 ]
  • 5-azido-1-phenyl-1<i>H</i>-tetrazole [ No CAS ]
  • 85
  • [ 5378-52-9 ]
  • acetone-(1-phenyl-1<i>H</i>-tetrazol-5-ylhydrazone) [ No CAS ]
Same Skeleton Products
Historical Records